The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chopas James George since 2021.
This trader's CIK number is 1836430.
At the time of last reporting, Chopas James George was the VP/Chief Accounting Officer of Apellis Pharmaceuticals, Inc.. (stock ticker symbol APLS).
Also see all insider trading activities at Apellis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APLS | 0 | $0 | 3,325 | $97,166 | 0 | $0 |
| 2024 | APLS | 0 | $0 | 1,795 | $101,068 | 0 | $0 |
| 2023 | APLS | 0 | $0 | 683 | $28,791 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | RDUS | 0 | $0 | 370 | $7,725 | 0 | $0 |
1. Apellis Pharmaceuticals, Inc. (APLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | APLS | Sale | 548 | 28.08 | 15,386 |
| 2025-03-17 | APLS | Sale | 183 | 24.82 | 4,542 |
| 2025-01-22 | APLS | Sale | 1,096 | 30.43 | 33,346 |
| 2025-01-17 | APLS | Sale | 715 | 29.96 | 21,419 |
| 2025-01-13 | APLS | Sale | 783 | 28.70 | 22,473 |
| 2024-09-03 | APLS | Sale | 550 | 39.49 | 21,720 |
| 2024-03-15 | APLS | Sale | 184 | 56.46 | 10,388 |
| 2024-01-22 | APLS | Sale | 1,061 | 65.00 | 68,960 |
| 2023-10-23 | APLS | Sale | 132 | 46.04 | 6,076 |
| 2023-08-31 | APLS | Sale | 551 | 41.23 | 22,715 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-05 | RDUS | Sale | 370 | 20.88 | 7,725 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chopas James George (VP/Chief Accounting Officer of Apellis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.